ꢀ
G.B. Cserep et al. / Tetrahedron xxx (2014) 1e5
4
4.2. Synthesis
J1¼8.9 Hz, J2¼2.4 Hz), 6.76 (1H, dd, J1¼16.6 Hz, J2¼9.9 Hz), 7.41 (1H,
d, J¼8.9 Hz), 8.39 (1H, s), 8.5 (1H, s). 13C NMR (CDCl3, 62.5 MHz):
4.2.1. 3-(2-(Vinylsulfonyl)ethoxy)prop-1-yne (1). To
propargyl alcohol (120
in anhydrous THF (15 mL) under argon atmosphere was added
dropwise a suspension of BuOK (46 mg, 0.41 mmol) in anhydrous
a
solution of
d
¼12.4, 45.0, 55.0, 63.9, 64.4, 97.0, 107.0, 110.1, 116.6, 123.7, 129.1,
m
L, 2.05 mmol) and DVS (820
mL, 8.20 mmol)
130.0, 134.8, 137.7, 143.7, 151.7, 155.8, 156.9. HRMS (ESI): [MþH]þ
calcd for C20H25N4O5Sþ: 433.1546, found: 433.1544.
t
THF (20 mL). The reaction mixture was stirred at room temperature
for 45 min when TLC (DCM:MeOH/200:1) showed total conversion
of the alcohol. After evaporation of the solvent the product was
extracted with EtOAc (5ꢀ10 mL) and purified on silica (DCM:MeOH/
500:1) to give 174 mg (49%) of the desired product as a colorless oil.
4.2.5. 7-(Diethylamino)-3-(4-((2-(2-(vinylsulfonyl)ethoxy)ethoxy)-
methyl)-1H-1,2,3-triazol-1-yl)-coumarin
(4b). 7-Diethylamino-3-
azido-coumarin (70 mg, 0.28 mmol) and 3-(2-(vinylsulfonyl)-eth-
oxy)-prop-1-yne (1) (63 mg, 0.28 mmol) were dissolved in MeCN
(10 mL) and triethylamine (50 mL) and CuI (53 mg, 0.28 mmol) were
Rf¼0.28 (DCM:MeOH/500:1). IR:
1386; 1445; 1612; 2116; 2877; 3060; 3269 cmꢁ1
250 MHz):
n
(neat)¼1095; 1126; 1311; 1358;
added. The mixture was stirred at room temperature for 1 h when
TLC (Hexane:EtOAc/1:1) showed completion of the reaction. After
evaporation of the solvent the product was extracted by EtOAc
(3ꢀ5 mL) from the brown residue and was purified on silica (Hex-
ane:EtOAc/1:1/1:3 gradient) to yield 67 mg (50%) product as
a yellowish powder. Rf¼0.12 (Hexane:EtOAc/1:2). Mp¼101e103 ꢂC.
.
1H NMR (CDCl3,
d
¼2.47 (1H, d, J¼2.3 Hz), 3.26 (2H, t, J¼5.6 Hz), 3.91 (2H, t,
J¼5.6 Hz), 4.14 (2H, d, J¼2.3 Hz), 6.09 (1H, d, J¼9.9 Hz), 6.38 (1H, d,
J¼16.6 Hz), 6.70 (1H, dd, J1¼16.6 Hz, J2¼9.9 Hz). 13C NMR (CDCl3,
62.5 MHz):
d
¼54.7, 58.4, 63.2, 75.4, 78.4, 129.2, 137.4. HRMS (ESI):
[MþH]þ calcd for C7H11O3Sþ: 175.0429, found: 175.0431.
IR:
n
(neat)¼1188,1243,1265,1291,1346,1381,1472,1596,1624,1695,
1714, 2870, 2904, 2976, 3060, 3160 cmꢁ1. 1H NMR (CDCl3, 250 MHz):
4.2.2. 2-(Prop-2-ynyloxy)ethanol (2). A solution of propargylbromide
(2.5 mL, 80% in toluene, 22.5 mmol) and ethylene glycol (2.5 mL) was
flushed with argon and cooled to 0 ꢂC in an ice bath. Powdered NaOH
(1.08 g, 45.0 mmol) was added and the reaction mixture was stirred
at 45 ꢂC for 3 h. The precipitate was filtered, washed with DCM
(2ꢀ3 mL), and the filtrate was extracted with DCM (3ꢀ10 mL). After
evaporation of the solvent the crude product was purified using silica
gel column chromatography (Hexane:EtOAc/2:1) to yield 1.34 g (60%)
d
¼1.22 (6H, t, J¼7.0 Hz), 3.25 (2H, t, J¼5.6 Hz), 3.44 (4H, q, J¼7.0 Hz),
3.67 (4H, m), 3.88 (2H, t, J¼5.6 Hz), 4.72 (2H, s), 6.07 (1H, dd,
J¼9.9 Hz), 6.36 (1H, d, J¼16.6 Hz) 6.53 (1H, s), 6.66 (1H, d, J¼8.9 Hz),
6.79 (1H, dd, J1¼16.6 Hz, J2¼9.9 Hz), 7.39 (1H, d, J¼8.9 Hz), 8.35 (1H,
s), 8.53 (1H, s). 13C NMR (CDCl3, 62.5 MHz):
d¼12.3, 44.9, 54.9, 64.3,
64.6, 69.2, 70.4, 96.9, 106.9, 110.0, 116.7, 123.6, 128.8, 130.0, 134.8,
137.8, 144.4, 151.5, 155.7, 156.9. HRMS (ESI): [MþH]þ calcd for
C
22H29N4O6Sþ: 477.1808, found: 477.1810.
of 2 as a pale yellow oil. Rf¼0.25 (Hexane:EtOAc/2:1). IR:
n
(neat)¼
1106; 1246; 1729; 2115; 2868; 2935; 3287; 3400 cmꢁ1
.
1H NMR
4.3. Peptide synthesis, tagging reactions
(CDCl3, 250 MHz):
d
¼2.42 (1H, t, J¼2.2 Hz), 2.99 (1H, s), 3.55 (2H, t,
J¼4.4 Hz), 3.66 (2H, t, J¼4.4 Hz), 4.12 (2H, d, J¼2.2 Hz). 13C NMR
4.3.1. Peptide synthesis. The peptides (DTHFPIC, KGDTHFPIC) were
synthesized manually by Fmoc/tBu solid phase strategy on Fmoc-
Rink Amide MBHA resin. The protocol of the synthesis was the
following: (i) Fmoc deprotection with 2% piperidine/2% DBU/DMF
(v/v), 2þ2þ5þ10 min; (ii) washing with DMF (5ꢀ1 min); (iii)
coupling with 3 equiv of Fmoc-amino acid derivativeeDICeHOBt
dissolved in NMP, 60 min; and (iv) washing with DMF (5ꢀ1 min).
Peptides were cleaved from the resin with the TFA/H2O/TIS
(9.5:2.5:2.5 v/v) mixture (2 h, RT). After filtration, compounds were
precipitated in cold diethyl ether, centrifuged (4000 rpm, 5 min),
and freeze-dried in water. Crude products were purified by semi-
preparative RP-HPLC. Purified peptides were analyzed by analyti-
cal RP-HPLC, ESI MS, and amino acid analysis (ESI).
(CDCl3, 62.5 MHz):
d
¼58.1, 61.2, 71.0, 74.6, 79.3. HRMS (ESI): [MþH]þ
calcd for C5H9Oþ2 : 101.0603, found: 101.0602.
4.2.3. 3-(2-(2-(Vinylsulfonyl)ethoxy)ethoxy)prop-1-yne (3). To a so-
lution of 2 (320 mg, 3.2 mmol) and DVS (480
mL, 4.8 mmol) in
anhydrous THF (15 mL) under argon atmosphere was added
t
dropwise a suspension of BuOK (72 mg, 0.71 mmol) in anhydrous
THF (30 mL). The reaction mixture was stirred at room temperature
for 45 min when TLC (Hexane:EtOAc/5:3) showed total conversion
of the alcohol. After evaporation of the solvent the product was
extracted by EtOAc (5ꢀ10 mL) and purified on silica (Hex-
ane:EtOAc/2:1) to give 402 mg (58%) pale yellow oil. Rf¼0.27
(Hexane:EtOAc 5:3). IR:
n
(neat)¼1122; 1353; 1385; 1461; 2115;
2872; 3266 cmꢁ1 1H NMR (CDCl3, 250 MHz):
.
d
¼2.43 (1H, d,
4.3.2. Synthesis of KGDTHFPIC-3. 7.6 mg (7.5
peptide was dissolved in 1000 L 50 mM HEPES buffer (pH 8.0) and
2.4 mg (11.2 mol, 1.5 equiv) 3 in 100 L DMF was added to the
mmol) KGDHTFPIC
J¼2.4 Hz), 3.24 (2H, t, J¼5.7 Hz), 3.64 (4H, m), 3.87 (2H, t, J¼5.7 Hz),
4.16 (d, 2H, J¼2.4 Hz), 6.06 (1H, d, J¼9.9 Hz), 6.36 (1H, d, J¼16.6 Hz),
6.78 (1H, dd, J1¼16.6 Hz, J2¼9.9 Hz). 13C NMR (CDCl3, 62.5 MHz):
m
m
m
peptide. The reaction was stirred at room temperature and moni-
tored by analytical RP-HPLC. The reaction was totally completed
after 1 h. The product was purified by semi-preparative RP-HPLC
and analyzed by analytical RP-HPLC, ESI MS, MS/MS (see ESI).
d
¼54.9, 58.2, 64.6, 68.6, 70.2, 74.7, 79.3, 128.7, 137.8. HRMS (ESI):
[MþH]þ calcd for C9H15O4Sþ [MþH]þ: 219.0691, found: 219.0689.
4.2.4. 7-(Diethylamino)-3-(4-((2-(vinylsulfonyl)ethoxy)methyl)-1H-
1,2,3-triazol-1-yl)-coumarin (4a). 7-Diethylamino-3-azido-couma-
rin (100 mg, 0.39 mmol) and 3-(2-(vinylsulfonyl)ethoxy)-prop-1-
yne (1) (67 mg, 0.39 mmol) were dissolved in MeCN (10 mL) and
4.3.3. Synthesis of KGDTHFPIC-4b. Route A: 1.0 mg (0.8
KGDHTFPIC-3 was dissolved in 287 L 50 mM HEPES buffer (pH
8.0). 203 L 10 mM sodium -ascorbate (2.5 equiv) solution in
50 mM HEPES buffer (pH 8.0) and 203 L 10 mM CuSO4eTBTA
(2.5 equiv) solution (55% DMSO, 45% distilled water) was prepared
and combined. To this mixture 418 g (1.6 mol, 2 equiv) 5 in 287
DMSO and the 287 L solution of KGDTHFPIC-3 was added finally.
The reaction was stirred at room temperature and monitored by
analytical RP-HPLC. The reaction was completed after 24 h. The
product was purified by semipreparative RP-HPLC and analyzed by
analytical RP-HPLC, ESI MS, MS/MS (ESI).
mmol)
m
m
L
triethylamine (50
mL) and CuI (7.4 mg, 0.039 mmol) were added.
m
The mixture was stirred at room temperature for 1 h when TLC
(Hexane:EtOAc/1:1) showed completion of the reaction. After
evaporation of the solvent the product was extracted by EtOAc
(3ꢀ5 mL) purified on silica (Hexane:EtOAc/1:1/1:3 gradient) to
yield 62 mg (37%) yellowish powder. Rf¼0.14 (Hexane:EtOAc 1:1).
m
m
mL
m
Mp¼152e154 ꢂC. IR:
(neat)¼1249; 1291; 1432; 1465; 1484; 1526;
n
1596; 1621; 1708; 2875; 2925; 3069; 3179 cmꢁ1. 1H NMR (CDCl3,
250 MHz):
d
¼1.24 (6H, t, J¼7.1 Hz), 3.28 (2H, t, J¼5.6 Hz), 3.46 (4H,
Route B: 2.5 mg (2.5
400 L 50 mM HEPES buffer (pH 8.0) and 2.3 mg (4.9
4b in 400 L DMF was added to the peptide. The reaction was
m
mol) KGDHTFPIC peptide was dissolved in
q, J¼7.1 Hz), 3.97 (2H, t, J¼5.6 Hz), 4.72 (2H, s), 6.10 (1H, d, J¼9.9 Hz),
m
mmol, 2 equiv)
6.40 (1H, d, J¼16.6 Hz), 6.55 (1H, d, J¼2.4 Hz), 6.68 (1H, dd,
m
ꢀ